You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 553 CUE-100 series Immuno-STATs from concept to the clinic: Leveraging protein engineering to stimulate and selectively deliver affinity-attenuated IL-2 to antigen-specific T cells

Citation Tools

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Immune-stimulants and immune modulators
553 CUE-100 series Immuno-STATs from concept to the clinic: Leveraging protein engineering to stimulate and selectively deliver affinity-attenuated IL-2 to antigen-specific T cells

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Histed A, Girgis N, Moreta M, et al
553 CUE-100 series Immuno-STATs from concept to the clinic: Leveraging protein engineering to stimulate and selectively deliver affinity-attenuated IL-2 to antigen-specific T cells
Journal for ImmunoTherapy of Cancer 2020;8:doi: 10.1136/jitc-2020-SITC2020.0553